BIOMAT Database Logo BIOMAT Database Logo

Disappearance of a tumor-associated antigen in malignant melanoma after imidazole carboxamide therapy. 1971

L Nathanson, and U Jehn, and R S Schwartz

UI MeSH Term Description Entries
D001797 Blood Protein Electrophoresis Electrophoresis applied to BLOOD PROTEINS. Hemoglobin Electrophoresis,Electrophoresis, Blood Protein,Electrophoresis, Hemoglobin,Protein Electrophoresis, Blood
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001391 Azo Compounds Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N Azo Dye,Azo Dyes,Compounds, Azo,Dye, Azo,Dyes, Azo

Related Publications

L Nathanson, and U Jehn, and R S Schwartz
Imidazole carboxamide therapy in advanced malignant melanoma.
March 1971, Cancer,
L Nathanson, and U Jehn, and R S Schwartz
Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea.
December 1972, Cancer,
L Nathanson, and U Jehn, and R S Schwartz
Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
January 1977, Cancer,
L Nathanson, and U Jehn, and R S Schwartz
Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
January 1971, Clinical pharmacology and therapeutics,
L Nathanson, and U Jehn, and R S Schwartz
Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
October 1973, Cancer,
L Nathanson, and U Jehn, and R S Schwartz
Intra-arterial therapy of melanoma with dimethyl triazeno imidazole carboxamide (NSC-45388).
November 1971, Cancer,
L Nathanson, and U Jehn, and R S Schwartz
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
September 1974, The New England journal of medicine,
L Nathanson, and U Jehn, and R S Schwartz
Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
October 1973, Cancer,
L Nathanson, and U Jehn, and R S Schwartz
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
June 1976, Clinical pharmacology and therapeutics,
L Nathanson, and U Jehn, and R S Schwartz
A tumor-associated antigen expressed in melanoma cells with lower malignant potential.
June 1985, International journal of cancer,
Copied contents to your clipboard!